| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
CRC Cell Proliferation Unit, Department of Histopathology, Royal Postgraduate Medical School, Hammersmith Hospital, DuCane Road, London W12 OHS, England
A new cell line, HCA-7, has been established from a primary human colonic adenocarcinoma. The HCA-7 cells have an epithelial morphology by phase-contrast microscopy, they secrete carcinoembryonic antigen, and they form adenocarcinomas when injected s.c. into nude mice.
HCA-7 cells retain some of the morphological and functional polarity exhibited by normal colonic epithelium. Cells form a polarized epithelial sheet when grown on tissue culture plastic in standard culture medium (Dulbecco's modification of Eagle's medium with 10% fetal calf serum). The cells were shown to be structurally polarized with sparse microvilli present at the apical surface but absent from the basolateral surface. Cells were connected by apical tight junctions and frequent desmosomes. Confluent monolayers of HCA-7 cells formed "domes" or "hemicysts" due to vectorial fluid transport resulting in fluid accumulation in localized areas of the monolayer.
HCA-7 cells will provide a useful system for studying the role of hormones and other factors in the control of transepithelial transport and maintenance of cell polarity.
1 This work was supported by a Cancer Research Campaign grant awarded to Professor N. A. Wright.
Received 12/10/84. Revised 3/20/85. Accepted 3/27/85.
This article has been cited by other articles:
![]() |
Y.-W. E. Chang, J. W. Marlin, T. W. Chance, and R. Jakobi RhoA Mediates Cyclooxygenase-2 Signaling to Disrupt the Formation of Adherens Junctions and Increase Cell Motility Cancer Res., December 15, 2006; 66(24): 11700 - 11708. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y Shoji, M Takahashi, T Kitamura, K Watanabe, T Kawamori, T Maruyama, Y Sugimoto, M Negishi, S Narumiya, T Sugimura, et al. Downregulation of prostaglandin E receptor subtype EP3 during colon cancer development Gut, August 1, 2004; 53(8): 1151 - 1158. [Abstract] [Full Text] [PDF] |
||||
![]() |
L Jackson, W Wahli, L Michalik, S A Watson, T Morris, K Anderton, D R Bell, J A Smith, C J Hawkey, and A J Bennett Potential role for peroxisome proliferator activated receptor (PPAR) in preventing colon cancer Gut, September 1, 2003; 52(9): 1317 - 1322. [Abstract] [Full Text] |
||||
![]() |
H. Sawaoka, D. A. Dixon, J. A. Oates, and O. Boutaud Tristetraprolin Binds to the 3'-Untranslated Region of Cyclooxygenase-2 mRNA. A POLYADENYLATION VARIANT IN A CANCER CELL LINE LACKS THE BINDING SITE J. Biol. Chem., April 11, 2003; 278(16): 13928 - 13935. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. H. Mellits, J. Mullen, M. Wand, G. Armbruster, A. Patel, P. L. Connerton, M. Skelly, and I. F. Connerton Activation of the transcription factor NF-{kappa}B by Campylobacter jejuni Microbiology, September 1, 2002; 148(9): 2753 - 2763. [Abstract] [Full Text] [PDF] |
||||
![]() |
D Qualtrough, T Hinoi, E Fearon, and C Paraskeva Expression of CDX2 in normal and neoplastic human colon tissue and during differentiation of an in vitro model system Gut, August 1, 2002; 51(2): 184 - 190. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. A. Gupta, J. Tan, W. F. Krause, M. W. Geraci, T. M. Willson, S. K. Dey, and R. N. DuBois Prostacyclin-mediated activation of peroxisome proliferator-activated receptor delta in colorectal cancer PNAS, November 21, 2000; 97(24): 13275 - 13280. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. E. Crew, D. J.E. Elder, and C. Paraskeva A cyclooxygenase-2 (COX-2) selective non-steroidal anti-inflammatory drug enhances the growth inhibitory effect of butyrate in colorectal carcinoma cells expressing COX-2 protein: regulation of COX-2 by butyrate Carcinogenesis, January 1, 2000; 21(1): 69 - 77. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Beltinger, B. C. McKaig, S. Makh, W. A. Stack, C. J. Hawkey, and Y. R. Mahida Human colonic subepithelial myofibroblasts modulate transepithelial resistance and secretory response Am J Physiol Cell Physiol, August 1, 1999; 277(2): C271 - C279. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Beltinger, C. J. Hawkey, and W. A. Stack TGF-alpha reduces bradykinin-stimulated ion transport and prostaglandin release in human colonic epithelial cells Am J Physiol Cell Physiol, April 1, 1999; 276(4): C848 - C855. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Kirkland and K Henderson Endocrine and mucous differentiation by a cloned human rectal adenocarcinoma cell line (HRA-19) in vitro: inhibition by TGF-beta 1 J. Cell Sci., January 4, 1994; 107(4): 1041 - 1046. [Abstract] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |